SVB, MidCap Financial Provide $100MM Facility to Organogenesis
SVB and MidCap Financial entered a $100 million credit agreement with Organogenesis, a regenerative medicine company focused on product solutions for the advanced wound care and surgical and sports medicine markets.
March 15, 2019
Kevin Longo | MidCap Financial | Organogenesis | Silicon Valley Bank | SVB
Amanda Koprowski